View Single Post
Old 06-02-2015, 05:21 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,156
Perjeta regimen may help people with HER2-positive early breast cancer live longer wi

New data show that adding the personalised therapy, Perjeta to Herceptin® (trastuzumab) and docetaxel chemotherapy in the neoadjuvant setting (before surgery), may cut the risk of disease...

More...
News is offline   Reply With Quote